M.D. Prados
Department of Neurosurgery
University of California
San Francisco
USA
Name/email consistency: high
- Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. Prados, M.D., Scott, C., Curran, W.J., Nelson, D.F., Leibel, S., Kramer, S. J. Clin. Oncol. (1999)
- A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Prados, M.D., Scott, C., Sandler, H., Buckner, J.C., Phillips, T., Schultz, C., Urtasun, R., Davis, R., Gutin, P., Cascino, T.L., Greenberg, H.S., Curran, W.J. Int. J. Radiat. Oncol. Biol. Phys. (1999)
- Chemotherapy of brain tumors. Prados, M.D., Russo, C. Semin. Surg. Oncol (1998)
- Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Prados, M.D., Wara, W., Edwards, M.S., Ater, J., Rabbit, J., Lamborn, K., Davis, R., Levin, V.A. Pediatr. Neurosurg (1996)